echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Notice issued by Shenzhen: 30 best selling drugs have been reduced and affected by pharmaceutical enterprises such as Xi'an YANGSEN

    Notice issued by Shenzhen: 30 best selling drugs have been reduced and affected by pharmaceutical enterprises such as Xi'an YANGSEN

    • Last Update: 2018-06-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: saibelan 2018-06-06 yesterday (June 5), quanyao.com released the notice on publicizing the price reduction of some traded varieties in the purchase catalogue of Shenzhen Public Hospital Pharmaceutical Group, and the prices of 30 drugs were reduced According to the notice, the price reduction of these 30 varieties is due to the group's purchasing organization's price adjustment according to the market price change, and the publicity time is from June 5 to June 7, 2018 Appendix: the price of drugs in Shenzhen public hospital group's purchase catalogue has been reduced The price of drugs in the list of varieties has been reduced! As we all know, Shenzhen has once again become a pioneer in the reform of national drug procurement, especially in the aspect of centralized drug procurement, after taking the lead in implementing the "zero plus" of public hospital drugs nationwide On July 1, 2016, Shenzhen Municipal Commission of health and family planning issued the implementation plan for the pilot implementation of drug group procurement reform in public hospitals in Shenzhen It is required that from July, through the implementation of drug group procurement (GPO), the rise in drug costs in public hospitals can be effectively curbed, and drug price reduction can be achieved by 30% And promised that by 2017, the proportion of drug revenue in business revenue of the city's public hospitals will be reduced to less than 25% On December 12, 2017, Shenzhen Municipal Commission of health and family planning informed the media that the average price reduction of 1159 drugs purchased according to the second batch of GPO catalogues reached 22.57%, which is expected to save 1.537 billion yuan of drug costs for Shenzhen public hospitals throughout the year It is reported that, in terms of price reduction, the average reduction of more than two manufacturers' competitive varieties is 47.45%; the average reduction of anti infective drugs is 36.4% (source: Shenzhen health and Family Planning Commission) the number of procurement regulations has been greatly reduced In addition, according to the official data of Shenzhen health and Family Planning Commission, Shenzhen GPO procurement catalogue is also significantly "slimming down" In the catalogue, 2451 specifications and 40 dosage forms in the previous procurement channels were reduced to 1645 specifications and 21 dosage forms, and the number of specifications and dosage forms were reduced by 32.9% and 47.5% respectively (source: Shenzhen health and Family Planning Commission) up to now, Guangdong Province has announced the implementation of GPO procurement not only in Shenzhen, but also in Guangzhou, Dongguan, Foshan, etc Dongguan has been incorporated into the Shenzhen GPO platform for cross regional joint procurement, and the operator of Shenzhen GPO, quanyao.com, is also actively expanding the business of other cities in the province In July 2017, the general office of Guangzhou municipal government issued the notice on the implementation plan of comprehensive reform of public hospitals in Guangzhou, proposing to establish a GPO (drug centralized procurement organization) platform based on Guangzhou public resources trading center, promote the unified organization, centralized bidding and procurement of drugs (medical consumables) in public hospitals in Guangzhou, implement unified distribution and reduce circulation according to the requirements of centralized procurement with volume Link to control the cost of drugs (medical consumables) In April 2018, Guangdong pharmaceutical trading center and Foshan Municipal Bureau of human resources and social security held a strategic cooperation ceremony of "provincial and municipal co construction" Both parties decided to build "Foshan special area" with Foshan as the unit and relying on the third-party drug electronic trading platform of Guangdong Province, and Foshan Municipal Bureau of human resources and social security will organize public medical institutions to centrally purchase through the provincial platform In fact, in addition to Shanghai and Guangdong, GPO procurement is also being promoted all over the country In August 2017, Hubei issued the implementation opinions of the general office of the provincial people's Government on further reforming and improving the drug procurement and supply guarantee mechanism of public hospitals, proposing to introduce the third-party group procurement organization (GPO) In December 2017, Gansu Province issued the 2017 implementation plan for centralized procurement of drugs for medical institutions in Gansu Province, encouraging and promoting the implementation of GPO procurement and online shopping mall procurement by medical institutions consortia in different regions and at different levels As the purchase mode of quantity for price, GPO mode has made great contribution to drug price reduction Taking Shanghai as an example, as the first city to implement GPO procurement, the first batch of GPO procurement varieties in Shanghai are mainly anti microbial drugs, with an overall decrease of about 20.8% of the procurement amount Looking at Shenzhen GPO procurement, the average decline in anti infective drugs was 36.4% This time, GPO Shenzhen issued a price reduction notice again, many of which belong to anti infective drugs, that is to say, these drugs will be reduced again When is the price cut? Ask Qingtian about the wine How many ways can pharmaceutical enterprises resist under the bargaining of provincial procurement, volume procurement, GPO procurement and cross regional joint procurement?
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.